Fidia farmaceutici to attend the 2014 EULAR Congress in Paris

With a booth and a Satellite Symposium, a further confirmation of the Company's commitment in joint healthcare

FIDIA Farmaceutici S.p.A. will participate in the forthcoming Annual Congress of the European League Against Rheumatism (EULAR) that will take place from 11-14 June, 2014 at the Palais des Congrès in Paris, France.

The Company will be present in the Exhibition area with booth P07 (LEVEL 1), where Fidia's innovative portfolio in the OA area will be presented to the medical community, and with the Satellite Symposium entitled "Challenging the unmet needs in I.A.H.A. therapy", scheduled for June 12, 2014 (17.30 - 19.00).


Find out more about Fidia’s product portfolio:

Go to the website


Fidia Farmaceutici has a specific module dedicated to Pharmaco-Vigilance in order to promptly reporting of suspected adverse reactions. If you suspect that you have had an adverse reaction while taking one of our products or you have found defects

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine